Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             34 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of spleen lymphocytes by plasmid DNA Rykova, Elena Yu
1999
17 9-10 p. 1193-1200
8 p.
artikel
2 A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge Tao, T
1999
17 9-10 p. 1100-1108
9 p.
artikel
3 A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D 1 Presented in part: ASBMB/ASIP/AAI Joint Meeting, New Orleans, June 1996 (Abstract # 470) and Ph.D. thesis, Wright State University, August 1996. 1 Cruz, P.E.
1999
17 9-10 p. 1091-1099
9 p.
artikel
4 A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice Babai, Ilan
1999
17 9-10 p. 1239-1250
12 p.
artikel
5 A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice Babai, Ilan
1999
17 9-10 p. 1223-1238
16 p.
artikel
6 Biodegradable microspheres containing influenza A vaccine: immune response in mice Hilbert, Anne K
1999
17 9-10 p. 1065-1073
9 p.
artikel
7 Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice Guy, B
1999
17 9-10 p. 1130-1135
6 p.
artikel
8 Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin Hayward, Christopher M.M
1999
17 9-10 p. 1272-1281
10 p.
artikel
9 Correspondence 1999
17 9-10 p. 1016-
1 p.
artikel
10 Correspondence 1999
17 9-10 p. 1015-
1 p.
artikel
11 Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge Dean, H.J
1999
17 9-10 p. 1117-1124
8 p.
artikel
12 Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination Krüger, Sabine
1999
17 9-10 p. 1145-1150
6 p.
artikel
13 Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system Maes, D
1999
17 9-10 p. 1024-1034
11 p.
artikel
14 Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization Cho, Jae Ho
1999
17 9-10 p. 1136-1144
9 p.
artikel
15 Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid Chengalvala, Murty V
1999
17 9-10 p. 1035-1041
7 p.
artikel
16 Evaluation of a new recombinant DNA hepatitis B vaccine (Shanvac-B) Abraham, Philip
1999
17 9-10 p. 1125-1129
5 p.
artikel
17 Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis De Luca, Paula M
1999
17 9-10 p. 1179-1185
7 p.
artikel
18 Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors 1 In conducting the research described in this report, the investigators adhered to the Guide for Care and Use of Laboratory Animals, as promulgated by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council. The facilities are fully accredited by the American Association for Accreditation of Laboratory Animal Care. The views of the authors do not purport to reflect the positions of the Department of the Army or the Department of Defense. 1 Hodgson, Loreen A.
1999
17 9-10 p. 1151-1160
10 p.
artikel
19 Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide Sturgess, Annie W
1999
17 9-10 p. 1169-1178
10 p.
artikel
20 Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide Leibl, Heinz
1999
17 9-10 p. 1017-1023
7 p.
artikel
21 Immunization of dogs and cats with a DNA vaccine against rabies virus Osorio, J.E
1999
17 9-10 p. 1109-1116
8 p.
artikel
22 Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man Niedrig, M
1999
17 9-10 p. 1206-1210
5 p.
artikel
23 MHC class I- and class II-restricted processing and presentation of microencapsulated antigens Men, Ying
1999
17 9-10 p. 1047-1056
10 p.
artikel
24 Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants Gherardi, M.Magdalena
1999
17 9-10 p. 1074-1083
10 p.
artikel
25 Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites Franke, Eileen D
1999
17 9-10 p. 1201-1205
5 p.
artikel
26 Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory Matsuki, Naoto
1999
17 9-10 p. 1161-1168
8 p.
artikel
27 Production of a highly immunogenic subunit ISCOM vaccine against Bovine Viral Diarrhea Virus Kamstrup, S.
1999
17 9-10 p. 1057-1064
8 p.
artikel
28 Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus Piirainen, Liisa
1999
17 9-10 p. 1084-1090
7 p.
artikel
29 Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine Stefano, Isabel
1999
17 9-10 p. 1042-1046
5 p.
artikel
30 Secondary vaccination with vaccinia virus recombinants: role of residual virulence of recombinants and immunogenicity of extrinsic antigens Kutinová, Luda
1999
17 9-10 p. 1186-1192
7 p.
artikel
31 Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines Costantino, Paolo
1999
17 9-10 p. 1251-1263
13 p.
artikel
32 The business of science and the science of business in the quest for an AIDS vaccine 1 Presented in abbreviated content at the 1998 Meeting of the Institute of Human Virology, Baltimore, MD, August 24, 1998. 1 Hilleman, Maurice R
1999
17 9-10 p. 1211-1222
12 p.
artikel
33 The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines Wilson, A.D
1999
17 9-10 p. 1282-1290
9 p.
artikel
34 Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D Haagmans, Bart L
1999
17 9-10 p. 1264-1271
8 p.
artikel
                             34 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland